Follow
Philip Ashton-Rickardt
Philip Ashton-Rickardt
Chief Scientific Officer Sigilon Therapeutics
Verified email at smiththerapeutics.com
Title
Cited by
Cited by
Year
Evidence for a differential avidity model of T cell selection in the thymus
PG Ashton-Rickardt, A Bandeira, JR Delaney, L Van Kaer, HP Pircher, ...
Cell 76 (4), 651-663, 1994
9001994
TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4− 8+ T cells
L Van Kaer, PG Ashton-Rickardt, HL Ploegh, S Tonegawa
Cell 71 (7), 1205-1214, 1992
8751992
Altered peptidase and viral-specific T cell response in LMP2 mutant mice
L Van Kaert, PG Ashton-Rickardt, M Eichelberger, M Gaczynska, ...
Immunity 1 (7), 533-541, 1994
5431994
Linear differentiation of cytotoxic effectors into memory T lymphocytes
JT Opferman, BT Ober, PG Ashton-Rickardt
Science 283 (5408), 1745-1748, 1999
4961999
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective
JC Shepherd, TNM Schumacher, PG Ashton-Rickardt, S Imaeda, ...
Cell 74 (3), 577-584, 1993
4641993
A differential-avidity model for T-cell selection
PG Ashton-Rickardt, S Tonegawa
Immunology today 15 (8), 362-366, 1994
3321994
Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus
PG Ashton-Rickardt, L Van Kaer, TNM Schumacher, HL Ploegh, ...
Cell 73 (5), 1041-1049, 1993
3231993
Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator.
TN Schumacher, DV Kantesaria, MT Heemels, PG Ashton-Rickardt, ...
The Journal of experimental medicine 179 (2), 533-540, 1994
2681994
Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules
MA Markiewicz, C Girao, JT Opferman, J Sun, Q Hu, AA Agulnik, ...
Proceedings of the National Academy of Sciences 95 (6), 3065-3070, 1998
2291998
The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression …
CE Hirst, MS Buzza, CH Bird, HS Warren, PU Cameron, M Zhang, ...
The Journal of Immunology 170 (2), 805-815, 2003
2102003
Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules
M Zhang, SM Park, Y Wang, R Shah, N Liu, AE Murmann, CR Wang, ...
Immunity 24 (4), 451-461, 2006
1622006
NF‐κB protects from the lysosomal pathway of cell death
N Liu, SM Raja, F Zazzeroni, SS Metkar, R Shah, M Zhang, Y Wang, ...
The EMBO journal, 2003
1562003
C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism
GS Ling, G Crawford, N Buang, I Bartok, K Tian, NM Thielens, I Bally, ...
Science 360 (6388), 558-563, 2018
1532018
Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and …
A Oxenius, MF Bachmann, PG Ashton‐Rickardt, S Tonegawa, ...
European journal of immunology 25 (12), 3402-3411, 1995
1251995
Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes
Q Hu, CRB Walker, C Girao, JT Opferman, J Sun, J Shabanowitz, DF Hunt, ...
Immunity 7 (2), 221-231, 1997
1141997
Role of IL-35 in sublingual allergen immunotherapy
MH Shamji, JA Layhadi, D Achkova, L Kouser, A Perera-Webb, ...
Journal of Allergy and Clinical Immunology 143 (3), 1131-1142. e4, 2019
1052019
Serine protease inhibitor 2A is a protective factor for memory T cell development
N Liu, T Phillips, M Zhang, Y Wang, JT Opferman, R Shah, ...
Nature immunology 5 (9), 919-926, 2004
1052004
A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis
T Phillips, JT Opferman, R Shah, N Liu, CJ Froelich, PG Ashton-Rickardt
The Journal of Immunology 173 (6), 3801-3809, 2004
892004
Positive selection of self-and alloreactive CD8+ T cells in Tap-1 mutant mice.
CJ Aldrich, HG Ljunggren, L Van Kaer, PG Ashton-Rickardt, S Tonegawa, ...
Proceedings of the National Academy of Sciences 91 (14), 6525-6528, 1994
751994
The granule pathway of programmed cell death
PG Ashton-Rickardt
Critical Reviews™ in Immunology 25 (3), 2005
722005
The system can't perform the operation now. Try again later.
Articles 1–20